Income Statement

AMPHASTAR PHARMACEUTICALS, INC.

AMPH
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY
Revenue
719.89 731.97 644.40 498.99 437.77 349.85 322.36 294.67 240.18 255.17 251.52 210.46
Cost of Revenue
363.83 358.11 293.27 250.13 238.03 206.51 190.43 187.68 149.38 150.98 174.17 159.21
Gross Profit
356.06 373.86 367.33 256.71 209.72 151.65 136.58 113.22 96.80 106.10 77.35 52.72
Operating Expenses
215.65 168.44 154.13 141.36 129.85 132.39 131.96 115.61 91.69 88.50 84.25 69.24
Research & Development
85.84 73.91 73.74 74.77 60.93 67.23 68.85 57.56 43.42 41.20 37.07 28.43
Selling, General & Administrative
85.93 56.72 51.54 45.06 51.43 50.38 50.28 49.89 44.46 41.83 41.50 34.81
Other Operating Expenses
- - - - - - - - - - - -
Operating Income
140.40 205.42 213.19 115.35 79.86 19.26 4.61 -2.39 5.11 17.60 -6.90 -16.52
Non-Operating Income
-16.78 -15.66 -25.63 8.54 14.25 -6.32 60.27 -1.30 2.52 -0.75 -3.47 -0.17
Interest Income
8.68 10.61 5.46 1.32 0.60 0.64 1.00 0.46 0.43 0.27 0.32 0.24
Interest Expense
8.90 8.90 27.16 1.85 0.89 0.37 0.12 0.24 0.83 1.02 0.99 0.61
Other Non-Op Income / Expense
0.02 0.57 2.00 1.20 0.20 -6.59 59.39 -1.52 2.92 0.01 -2.79 0.20
Income Before Tax
123.62 189.76 171.36 116.04 84.14 4.64 60.23 -9.93 1.62 14.95 -10.36 -18.15
Income Tax Expense
25.53 30.25 33.81 24.65 22.02 3.23 11.29 -4.19 -2.89 4.41 -7.58 -7.45
Non-Controlling Interest
- - - - 1.19 -0.31 -2.43 -0.92 - - - -
Net Income
98.09 159.52 137.55 91.39 62.12 1.40 48.94 -5.74 4.51 10.53 -2.79 -10.70
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY
Depreciation & Amortization
- - - - - - - - - - - -
EBITDA
140.40 205.42 213.19 115.35 79.86 19.26 4.61 -2.39 5.11 17.60 -6.90 -16.52
Earnings Per Share (Basic)
2.10 3.29 2.85 1.88 1.30 0.03 1.04 -0.12 0.10 0.23 -0.06 -0.25
Diluted EPS
2.03 3.06 2.60 1.74 1.25 0.03 0.98 -0.12 0.09 0.22 -0.06 -0.25
Weighted Average Shares
46.74 48.43 48.27 48.55 47.78 47.04 46.98 46.40 46.11 45.38 44.96 41.96
Diluted Weighted Avg Shares
48.22 52.06 53.00 52.43 49.78 49.12 49.91 46.40 48.37 47.50 44.96 41.96
Comprehensive Income
101.96 158.82 137.69 89.53 59.07 2.37 48.27 -7.65 7.10 8.31 -3.61 -